ArticleEnvironmental science & technology2026
Benzalkonium Chloride-Induced Nephrotoxicity in 2D Cultures and a Human Kidney-on-a-Chip System.
Article in Environmental science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benzalkonium chlorides (BACs) are antimicrobial compounds widely used across a variety of settings, and the COVID-19 pandemic has led to significantly increased usage of BAC-containing products. Previous studies in animals have shown that the kidney is the primary site of BAC accumulation, whereas the liver does not accumulate BACs, likely due to efficient hepatic cytochrome P450-mediated metabolism. Thus, we hypothesized that low BAC-metabolizing capacity contributes to the extent of BAC buildup in the kidney and promotes subsequent kidney injury. Using 2D-cultured proximal tubule epithelial cells (PTECs), we found that renal metabolism is insufficient to detoxify BACs. We then assessed BACs' nephrotoxicity using a novel 3D "kidney-on-a-chip" microphysiological system (MPS). The MPS was exposed to C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.